Access Bio has ranked among the top searched stocks on 8 days within the past month.


As of 10:30 AM on the 14th, Access Bio is trading at 33,800 KRW, up 1.2% from the previous day. This marks a 48.25% increase compared to September 25. Access Bio is known as a specialized manufacturer of in vitro diagnostic products, including malaria diagnostic kits.

Over the past 5 days, individual investors have net purchased 816,374 shares, while foreign investors and institutions have net sold 865,868 shares and 1,780 shares, respectively.


On October 13, Access Bio became a market issue with the headline "Surge Following US Approval of COVID-19 Diagnostic Kit."



※Source: AI Investment Assistant AI Rasero


※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing